Overview

  • Product nameAnti-TRIF antibody
    See all TRIF primary antibodies
  • Description
    Rabbit polyclonal to TRIF
  • Tested applicationsSuitable for: WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide, corresponding to amino acids 143-158 of Mouse TRIF.

  • Positive control
    • Tested with mouse spleen lysate.

Properties

Applications

Our Abpromise guarantee covers the use of ab13810 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 66 kDa.
IHC-P Use at an assay dependent concentration.

Target

  • FunctionInvolved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.
  • Tissue specificityUbiquitously expressed but with higher levels in liver.
  • Sequence similaritiesContains 1 TIR domain.
  • DomainThe N-terminal region is essential for activation of the IFNB promoter activity.
  • Post-translational
    modifications
    Phosphorylated by TBK1.
  • Information by UniProt
  • Database links
  • Alternative names
    • IIAE6 antibody
    • MGC35334 antibody
    • MyD88 3 antibody
    • Proline rich vinculin and TIR domain containing protein B antibody
    • Proline-rich antibody
    • PRVTIRB antibody
    • Putative NF kappa B activating protein 502H antibody
    • Putative NF-kappa-B-activating protein 502H antibody
    • Putative NFkB activating protein antibody
    • TCAM1_HUMAN antibody
    • TICAM 1 antibody
    • TICAM-1 antibody
    • Ticam1 antibody
    • TIR domain containing adapter molecule 1 antibody
    • TIR domain containing adapter protein inducing IFN beta antibody
    • TIR domain containing adaptor inducing interferon beta antibody
    • TIR domain-containing adapter molecule 1 antibody
    • TIR domain-containing adapter protein inducing IFN-beta antibody
    • Toll interleukin 1 receptor domain containing adapter protein inducing interferon beta antibody
    • Toll like receptor adaptor molecule 1 antibody
    • Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta antibody
    • TRIF antibody
    • TRIF protein antibody
    • vinculin and TIR domain-containing protein B antibody
    see all

Anti-TRIF antibody images

  • Western blot analysis of TICAM in mouse spleen lysate using ab13810 at 1:1000 dilution.

    Western blot analysis of TICAM in mouse spleen lysate using ab13810 at 1:1000 dilution.
  • ab13810 (2µg/ml) staining TRIF in human colon using an automated system (DAKO Autostainer Plus). Using this protocol there is strong staining of mucosal cell cytoplasm.
    Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

References for Anti-TRIF antibody (ab13810)

This product has been referenced in:
  • Garcia PV  et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer 16:422 (2016). WB, IHC . Read more (PubMed: 27389279) »
  • Garcia PV  et al. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. Int J Clin Exp Pathol 8:4427-43 (2015). WB ; Rat . Read more (PubMed: 26191134) »

See all 11 Publications for this product

Product Wall

Application Western blot
Loading amount 25 µg
Gel Running Conditions Reduced Denaturing
Sample Mouse Cell lysate - whole cell (liver)
Specification liver
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 23°C
Username

Abcam user community

Verified customer

Submitted Nov 10 2014

Thank you for letting me know that the antibody reached you safely. The colour of antibodies does vary slightly depending on how they were purified and the buffer which they are stored in. ab13810 is a preparation of whole antiserum from rabbit and it ...

Read More

Thank you for the swift reply. I have arranged for a free of charge replacement of a different lot to be sent to you directly (Order number:xxxxx number:xxxxxx). This should be with you tomorrow. I would be very grateful if you could find the time to a...

Read More

Thank you for contacting us again. I am very sorry that the email we tried to send did not reach you. As discussed over the phone these are the details I will need in order to organise the replacement for you: Lot number Purchase order number or prefer...

Read More
Application Western blot
Sample Human Cell lysate - whole cell (macrophages)
Loading amount 25000 cells
Specification macrophages
Gel Running Conditions Reduced Denaturing
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Abcam user community

Verified customer

Submitted Jan 29 2008

Application Western blot
Sample Human Cell lysate - whole cell (THP1 human monocytes)
Loading amount 15 µg
Specification THP1 human monocytes
Treatment LPS time course
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5%
Username

Abcam user community

Verified customer

Submitted May 30 2007

Thank you for your enquiry. I have been in contact with the originator of this antibody, and they used mouse spleen from an adult Balb/c, approximately 6 months old. With that knowledge, I would recommend the 14 day old lysate over the 7 day old lysate...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"